Literature DB >> 21901759

Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia.

Monica M Holley1, Yongqing Zhang, Elin Lehrmann, William H Wood, Kevin G Becker, Tammy Kielian.   

Abstract

Microglia are the resident mononuclear phagocytes of the CNS parenchyma and represent an initial line of defense against invading microorganisms. Microglia utilize Toll-like receptors (TLRs) for pathogen recognition and TLR2 specifically senses conserved motifs of gram-positive bacteria including lipoproteins, lipoteichoic acids, and peptidoglycan (PGN) leading to cytokine/chemokine production. Interestingly, primary microglia derived from TLR2 knockout (KO) mice over-expressed numerous IL-12 family members, including IL-12p40, IL-12p70, and IL-27 in response to intact S. aureus, but not the less structurally complex TLR2 ligands Pam3CSK4 or PGN. The ability of intact bacteria to augment IL-12 family member expression was specific for gram-positive organisms, since numerous gram-negative strains were unable to elicit exaggerated responses in TLR2 KO microglia. Inhibition of SYK or IRAK4 signaling did not impact heightened IL-12 family member production in S. aureus-treated TLR2 KO microglia, whereas PI3K, MAPK, and JNK inhibitors were all capable of restoring exaggerated cytokine expression to wild type levels. Additionally, elevated IL-12 production in TLR2 KO microglia was ablated by a TLR9 antagonist, suggesting that TLR9 drives IL-12 family member production following exposure to intact bacteria that remains unchecked in the absence of TLR2 signaling. Collectively, these findings indicate crosstalk between TLR2 and TLR9 pathways to regulate IL-12 family member production by microglia. The summation of TLR signals must be tightly controlled to ensure the timely cessation and/or fine tuning of cytokine signaling to avoid nonspecific bystander damage due to sustained IL-12 release.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901759      PMCID: PMC3217087          DOI: 10.1002/glia.21243

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  64 in total

1.  Analysis of microarray data using Z score transformation.

Authors:  Chris Cheadle; Marquis P Vawter; William J Freed; Kevin G Becker
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Yoshio Wakatsuki; Ivan J Fuss; Warren Strober
Journal:  Immunity       Date:  2006-08-31       Impact factor: 31.745

4.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

Review 5.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

6.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.

Authors:  F Re; J L Strominger
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

Review 7.  Toll-like receptor-dependent discrimination of streptococci.

Authors:  Sandra Santos-Sierra; Douglas T Golenbock; Philipp Henneke
Journal:  J Endotoxin Res       Date:  2006

8.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  PAGE: parametric analysis of gene set enrichment.

Authors:  Seon-Young Kim; David J Volsky
Journal:  BMC Bioinformatics       Date:  2005-06-08       Impact factor: 3.169

10.  Immunopathogenesis of brain abscess.

Authors:  Tammy Kielian
Journal:  J Neuroinflammation       Date:  2004-08-17       Impact factor: 8.322

View more
  6 in total

Review 1.  Toll-like receptor (TLR) and inflammasome actions in the central nervous system.

Authors:  Richa Hanamsagar; Mark L Hanke; Tammy Kielian
Journal:  Trends Immunol       Date:  2012-04-21       Impact factor: 16.687

2.  Staphylococcus aureus-induced immunosuppression mediated by IL-10 and IL-27 facilitates nasal colonisation.

Authors:  Alanna M Kelly; John M Leech; Sarah L Doyle; Rachel M McLoughlin
Journal:  PLoS Pathog       Date:  2022-07-01       Impact factor: 7.464

3.  Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia.

Authors:  Diogo Lobo-Silva; Guilhermina M Carriche; A Gil Castro; Susana Roque; Margarida Saraiva
Journal:  Glia       Date:  2017-06-15       Impact factor: 7.452

4.  Oligodeoxynucleotides containing unmethylated cytosine-guanine motifs are effective immunostimulants against pneumococcal meningitis in the immunocompetent and neutropenic host.

Authors:  S Ribes; L Zacke; S Nessler; N Saiepour; E Avendaño-Guzmán; M Ballüer; U K Hanisch; R Nau
Journal:  J Neuroinflammation       Date:  2021-02-02       Impact factor: 8.322

5.  Soluble C-Type Lectin-Receptor Ligands Stimulate ROS Production in Dendritic Cells and Potentiate Killing of MRSA as Well as the MRSA Induced IL-12 Production.

Authors:  Helene M S Eld; Peter R Johnsen; Emilie M Nielsen; Frederikke Z Jørgensen; Marie Lindstrøm-Svendsen; Mara Baldry; Hanne Ingmer; Hanne Frøkiær
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

6.  A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus.

Authors:  Jun Dai; Decui Pei; Baoning Wang; Yu Kuang; Laifeng Ren; Kang Cao; Bin Zuo; Jingjing Shao; Sha Li; Zhonghua Jiang; Hong Li; Mingyuan Li
Journal:  Virol J       Date:  2013-01-31       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.